GETI-B:STO
Getinge AB
276,20 SEK
arrow_upward
+1,84%(+5,00) 1 d
11 nov, 17:05:37 GMT+1 · SEK
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de GETI-B...
Abrir
271,20 SEK
Alto
277,10 SEK
Bajo
271,20 SEK
Cap. burs.
70,20 mil M
Vol. medio
529,97 mil
Volumen
142,58 mil
Dividendo
1,72 %
Dividendo trimestral
1,19 SEK
Fecha exdividendo
22 abr 2026
Ratio PER
26,61
Máximo en 52 sem.
283,00 SEK
Mínimo en 52 sem.
175,90 SEK
BPA
10,38 SEK
Acciones en circulación
254,15 M
N.º de empleados
12 mil
Abrir
271,20 SEK
Alto
277,10 SEK
Bajo
271,20 SEK
Cap. burs.
70,20 mil M
Vol. medio
529,97 mil
Volumen
142,58 mil
Dividendo
1,72 %
Dividendo trimestral
1,19 SEK
Fecha exdividendo
22 abr 2026
Ratio PER
26,61
Máximo en 52 sem.
283,00 SEK
Mínimo en 52 sem.
175,90 SEK
BPA
10,38 SEK
Acciones en circulación
254,15 M
N.º de empleados
12 mil
Noticias
De fuentes web y partners de noticias
www.lifesciencefocus.com
·
hace 5 horas
Stacy Beske to lead Getinge’s largest business area
Perfil
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
Acerca de Getinge AB